Literature DB >> 16794157

Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response.

Nina A Mayr1, William T C Yuh, Toshiaki Taoka, Jian Z Wang, Dee H Wu, Joseph F Montebello, Sanford L Meeks, Arnold C Paulino, Vincent A Magnotta, Mustafa Adli, Joel I Sorosky, Michael V Knopp, John M Buatti.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the patterns and distribution of tumor shape and its temporal change during radiation therapy (RT) in cervical cancer and the effect of tumor configuration changes on the correlation between region of interest (ROI)-based and diameter-based MRI tumor measurement.
MATERIALS AND METHODS: Serial MRI examinations (T1-weighted and T2-weighted images) were performed in 60 patients (age range, 29-75 years; mean, 53.3 years) with advanced cervical cancer (stages IB2-IVB/recurrent) who were treated with RT at four time points: start of RT, during RT (at 2-2.5 and at 4-5 weeks of RT), and post-RT. Tumor configuration was classified qualitatively into oval, lobulated, and complex based on MR film review. Two methods of tumor volume measurement were compared: ellipsoid computation of three orthogonal diameters (diameter based) and ROI volumetry by delineating the entire tumor volume on the MR workstation (ROI based). Temporal changes of tumor shape and the respective tumor volumes measured by the two methods were analyzed using linear regression analysis.
RESULTS: Most tumors (70%) had a non-oval (lobulated and complex) shape before RT and became increasingly irregular during and after RT: 84% at 2-2.5 weeks of RT (p = 0.037), 86% (p = 0.025) at 4-5 weeks, and 96% post-RT (p = 0.010), compared with 70% pre-RT. Diameter-based and ROI-based measurement correlated well before RT (r = 0.89) but not during RT (r = 0.68 at 2-2.5 weeks, r = 0.67 at 4-5 weeks of RT).
CONCLUSION: Most cervical cancers are not oval in shape pretherapy, and they become increasingly irregular during and after therapy because of nonconcentric tumor shrinkage. ROI-based volumetry, which can optimally measure irregular volumes, may provide better response assessment during treatment than diameter-based measurement.

Entities:  

Mesh:

Year:  2006        PMID: 16794157     DOI: 10.2214/AJR.05.0039

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  23 in total

Review 1.  Radiobiological considerations in combining doses from external beam radiotherapy and brachytherapy for cervical cancer.

Authors:  Ana M Tornero-López; Damián Guirado
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-02

2.  Volume Measurement by Diffusion-Weighted Imaging in Cervical Cancer.

Authors:  Shinya Fujii; Naoki Iwata; Chie Inoue; Naoko Mukuda; Takeru Fukunaga; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

3.  Diffuse intrinsic pontine glioma: is MRI surveillance improved by region of interest volumetry?

Authors:  Garan T Riley; Paul A Armitage; Ruth Batty; Paul D Griffiths; Vicki Lee; John McMullan; Daniel J A Connolly
Journal:  Pediatr Radiol       Date:  2014-08-21

4.  Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

Authors:  Karen Lim; Beth Erickson; Ina M Jürgenliemk-Schulz; David Gaffney; Carien L Creutzberg; Akila Viswanathan; Lorraine Portelance; Sushil Beriwal; Aaron Wolfson; Walter Bosch; Jennifer De Los Santos; Catheryn Yashar; Anuja Jhingran; Mahesh Varia; Issam El Naqa; Bronwyn King; Anthony Fyles
Journal:  Pract Radiat Oncol       Date:  2015-07-02

5.  Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer.

Authors:  William T C Yuh; Nina A Mayr; David Jarjoura; Dee Wu; John C Grecula; Simon S Lo; Susan M Edwards; Vincent A Magnotta; Steffen Sammet; Hualin Zhang; Joseph F Montebello; Jeffrey Fowler; Michael V Knopp; Jian Z Wang
Journal:  Invest Radiol       Date:  2009-06       Impact factor: 6.016

6.  Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: Results from a prospective study.

Authors:  Jian Xiao; Yuting Tan; Wenyun Li; Jiaying Gong; Zhiyang Zhou; Yan Huang; Jian Zheng; Yanhong Deng; Lei Wang; Junsheng Peng; Donglin Ren; Ping Lan; Jianping Wang
Journal:  Oncol Lett       Date:  2015-04-07       Impact factor: 2.967

Review 7.  Volumetric analysis at abdominal CT: oncologic and non-oncologic applications.

Authors:  Virginia B Planz; Meghan G Lubner; Perry J Pickhardt
Journal:  Br J Radiol       Date:  2018-11-30       Impact factor: 3.039

8.  Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.

Authors:  Nina A Mayr; William T C Yuh; David Jajoura; Jian Z Wang; Simon S Lo; Joseph F Montebello; Kyle Porter; Dongqing Zhang; D Scott McMeekin; John M Buatti
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

9.  Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study.

Authors:  M P Schmid; B Mansmann; M Federico; J C A Dimopoulous; P Georg; E Fidarova; W Dörr; R Pötter
Journal:  Strahlenther Onkol       Date:  2013-01-25       Impact factor: 3.621

10.  Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.

Authors:  Nina A Mayr; Jian Z Wang; Simon S Lo; Dongqing Zhang; John C Grecula; Lanchun Lu; Joseph F Montebello; Jeffrey M Fowler; William T C Yuh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-23       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.